Made in Switzerland

Designed, developed and manufactured in Switzerland

Distalmotion stands for and invests in reliable engineering at the technological frontier – technologies developed, engineered and manufactured by leading researchers, designers and assorted specialists in Switzerland. Dexter embodies the precision of robotic surgery and the reliability of Swiss engineering.

Based in Switzerland, Distalmotion has immediate access to best-in-class innovation, talent and the highest quality standards in manufacturing and engineering. This quality guarantee is specifically relevant for
medical devices – where patients matter most.

Our story

Distalmotion is a medical device company founded and based in Lausanne, Switzerland that serves as a trusted partner to hospitals and clinics worldwide, providing reliable and precise robotic surgery systems – designed, developed and manufactured in Switzerland.

Distalmotion was founded in 2012 as a spin-off from the Robotics Lab of the Swiss Federal Institute of Technology in Lausanne (EPFL).

Our Mission

Our mission is to remove the complexity out of robotic surgery in order to fast track its widespread adoption in minimally invasive care.

To do so, we have developed a surgical robot called Dexter that integrates seamlessly and without compromise into existing laparoscopic procedures. Dexter is the surgical robot that everyone has been waiting for – the first and only on-demand approach to robotic surgery – providing sought-after simplicity and versatility, making robotics accessible for a wider repertoire of procedures and enabling surgeons to leverage the benefits of robotic aid.

Our Vision

Our vision is to establish a new, global standard of care that allows everyone to access the benefits of robotic surgery for best-in-class minimally invasive care.

We are Distalmotion

Management team

An experienced leadership team with a proven industry track record

Michael Friedrich
  • Michael Friedrich

  • CEO
  • Former Founder and CEO of Aïmago (sold to Novadaq in 2014 for $12m). At Aïmago, Michael converted an early-stage technology into a FDA cleared / CE marked product with initial sales in Europe. Michael and most Aïmago investors have reinvested in Distalmotion.

Dr. Matthias Reif
  • Dr. Matthias Reif

  • Senior Vice President Sales & Marketing
  • Former Head of EMEA at Novadaq (sold to Stryker in 2017 for $701m) where he built the EMEA market and channels for fluorescent endoscopy systems. Previously at Olympus, for whom he worked in the German and US market. Matthias can draw on an extensive network of industry experts and thought leaders.

Alexandre Berthoud
  • Alexandre Berthoud

  • Senior Vice President Operations
  • Former COO at Biosafe (sold to GE Healthcare in 2016) where he built the company’s supply chain. Previously at Panalpina as Head of Operations based in Shanghai, China. Alex brings 20 years of experience in operations and supply chain to the table and has a track record of facilitating fast growth environments and scaling businesses.

Romain Farkas
  • Romain Farkas

  • Previously at Thermo Fisher Scientific, Biosafe (sold to GE) and Aïmago where he developed high-end complex laboratory equipment in Lausanne, Switzerland. Romain brings 10 years of experience in Research & Development with a strong taste for embedded systems design.

Media Kit

Find our media kit at the link below. Please direct press inquiries and requests for brand assets including logos and imagery to

  • Media Kit


Distalmotion is out to establish a new standard of care. This requires building an extraordinary team that is grounded in a firm set of values and embraces a vibrant team spirit. Follow the link below, or get in touch, to explore opportunities to join the team.

Job Opportunities